Publisher Correction: Novel immunotherapeutics against LGR5 to target multiple cancer types.

Abstract:

[Image: see text]

Authors:

H-C Chen, N Mueller, K Stott, C Kapeni, E Rivers, CM Sauer, F Beke, SJ Walsh, N Ashman, L O'Brien, A Rafati Fard, A Ghodsinia, C Li, F Joud, O Giger, I Zlobec, I Olan, SJ Aitken, M Hoare, R Mair, E Serrao, JD Brenton, A Garcia-Gimenez, SE Richardson, B Huntly, DR Spring, M-O Skjoedt, K Skjødt, M de la Roche, M de la Roche

Journal:

EMBO Mol Med

Citation info:

16(11):3026

Publication date:

1st Nov 2024

Full text

DOI